NOVARTIS AG - Ordinary Shares (NVS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class: Equity / Ordinary Shares
Symbol: NVS on NYSE
Shares outstanding: 2,181,288,547
Price per share: $137.87
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 133,879,058
Total reported value: $17,168,375,974
% of total 13F portfolios: 0.03%
Share change: +328,188
Value change: +$52,761,760
Number of holders: 1,379

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of NOVARTIS AG - Ordinary Shares (NVS) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	6.4%		$16,893,294,532		139,602,467		UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	30 Sep 2024

As of 30 Sep 2025, 1,379 institutional investors reported holding 133,879,058 shares of NOVARTIS AG - Ordinary Shares (NVS). This represents 6.1% of the company’s total 2,181,288,547 outstanding shares.

Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	1,112,489	$154,426,289	+$8,486,592			$137.87	124
2025 Q3	133,879,058	$17,168,375,974	+$52,761,760	$285,147,356	$198,601,947	$128.24	1,379
2025 Q2	133,423,708	$16,144,171,651	-$490,795,407	$205,384,174	$206,393,282	$121.01	1,369
2025 Q1	137,681,346	$15,355,489,132	+$873,070,989	$203,080,350	$182,184,777	$111.48	1,340
2024 Q4	130,470,605	$12,709,821,342	-$223,328,531	$151,659,018	$127,963,732	$97.31	1,334
2024 Q3	131,987,581	$15,201,056,989	-$627,584,183	$210,240,543	$128,312,996	$115.02	1,303
2024 Q2	137,719,910	$14,668,222,732	-$144,104,622	$163,567,784	$157,963,742	$106.46	1,301
2024 Q1	140,176,396	$13,569,198,383	-$108,755,788	$83,729,488	$111,432,960	$96.73	1,242
2023 Q4	141,021,080	$14,240,120,151	-$825,257,959	$167,489,036	$161,654,835	$100.97	1,268
2023 Q3	148,647,819	$15,101,329,049	+$2,385,866	$138,021,659	$138,254,578	$101.86	1,219
2023 Q2	148,412,479	$14,945,811,295	-$1,626,426,726	$160,831,953	$473,098,681	$100.91	1,196
2023 Q1	162,534,260	$14,927,486,538	-$603,160,694	$127,144,900	$268,817,400	$92.00	1,167
2022 Q4	170,732,151	$15,466,366,800	-$870,515,885	$182,084,608	$374,324,509	$90.72	1,178
2022 Q3	179,604,894	$13,655,041,391	-$1,517,874,336	$111,683,000	$194,765,000	$76.01	1,079
2022 Q2	199,549,854	$16,868,395,196	-$491,947,942	$99,800,000	$162,233,000	$84.53	1,132
2022 Q1	208,076,091	$18,259,605,452	-$256,111,310	$109,699,000	$197,116,000	$87.75	1,130
2021 Q4	211,034,733	$18,456,804,032	-$793,360,418	$121,198,000	$417,510,000	$87.47	1,139
2021 Q3	219,857,265	$17,981,524,870	+$259,818,203	$81,773,000	$371,758,000	$81.78	1,074
2021 Q2	216,752,152	$19,776,538,734	-$101,066,270	$43,503,000	$127,856,000	$91.24	1,115
2021 Q1	218,133,501	$18,649,888,527	-$803,320,984	$67,415,000	$139,771,000	$85.48	1,134
2020 Q4	227,852,721	$21,515,157,913	+$231,149,975	$103,115,000	$216,660,000	$94.43	1,174
2020 Q3	226,235,539	$19,668,553,299	-$999,534,657	$109,907,000	$168,280,472	$86.96	1,114
2020 Q2	237,639,327	$20,747,226,195	-$818,359,895	$93,027,000	$168,058,000	$87.34	1,126
2020 Q1	247,523,438	$20,413,284,538	-$920,198,014	$88,991,000	$137,576,000	$82.45	1,129
2019 Q4	257,558,012	$24,385,920,825	+$1,318,532,860	$118,860,000	$167,003,000	$94.69	1,165
2019 Q3	244,041,543	$21,209,045,275	-$1,136,669,640	$132,695,000	$142,949,000	$86.90	1,085
2019 Q2	257,146,236	$23,470,712,160	-$1,428,128,939	$103,568,000	$215,149,000	$91.31	1,089
2019 Q1	273,598,014	$26,233,179,236	+$85,016,997	$87,723,000	$143,864,000	$96.14	1,125
2018 Q4	272,691,525	$23,401,248,846	+$1,019,305,433	$70,878,000	$103,649,000	$85.81	1,081
2018 Q3	260,375,583	$22,434,768,761	+$468,539,231	$58,234,000	$82,943,000	$86.16	1,015
2018 Q2	255,168,529	$19,276,895,341	+$303,768,624	$25,842,000	$91,586,000	$75.54	980
2018 Q1	255,853,374	$20,683,549,265	+$332,779,564	$44,132,000	$80,230,000	$80.85	1,006
2017 Q4	250,469,954	$21,032,684,180	-$565,196,593	$41,736,000	$57,881,000	$83.96	998
2017 Q3	257,789,367	$22,129,485,306	-$116,562,133	$25,275,000	$41,346,000	$85.85	931
2017 Q2	259,321,539	$21,643,784,788	-$331,486,945	$42,053,000	$65,016,000	$83.47	913
2017 Q1	269,234,694	$19,983,591,444	+$1,289,749,366	$65,291,000	$27,790,000	$74.27	905
2016 Q4	251,930,600	$18,318,806,174	+$922,890,148	$76,409,000	$94,057,000	$72.84	901
2016 Q3	237,915,941	$18,784,888,663	+$42,701,849	$41,941,000	$40,001,000	$78.96	870
2016 Q2	234,713,550	$19,367,660,908	-$247,748,118	$49,568,000	$43,008,000	$82.51	873
2016 Q1	237,595,341	$17,239,475,619	+$303,216,392	$21,400,000	$28,809,000	$72.44	865
2015 Q4	235,807,146	$20,287,989,287	+$5,952,062	$41,168,000	$26,051,000	$86.04	925
2015 Q3	233,563,962	$21,466,211,680	+$233,941,546	$53,066,000	$40,460,000	$91.92	917
2015 Q2	235,083,304	$23,119,888,762	+$108,817,702	$17,975,000	$55,491,000	$98.34	939
2015 Q1	233,711,535	$23,050,928,826	-$45,009,237	$15,459,000	$30,507,000	$98.61	930
2014 Q4	234,784,196	$21,754,711,217	+$125,701,493	$66,938,000	$159,471,000	$92.66	910
2014 Q3	232,276,030	$21,863,219,060	-$331,053,568	$104,195,000	$176,503,000	$94.13	868
2014 Q2	236,112,249	$21,374,116,608	-$158,182,158	$103,170,000	$157,480,000	$90.53	841
2014 Q1	237,432,285	$20,184,244,285	-$372,335,530	$188,015,000	$166,082,000	$85.02	827